The Patent Finder

Avicena Group, Inc.

Also on record
Records under this name other than patents Avicena Group, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 6 of 6 · Back to Avicena Group, Inc.

PatentTitleStatus Expires Confidence
US 6,242,491Use of creatine or creatine compounds for skin preservation
Formerly held
Term ended
Term ended Jun 25, 2019 · From the USPTO record
Term endedTerm ended Jun 25, 2019From the USPTO record
US 7,186,754Use of creatine or creatine compounds for skin preservation
Formerly held
Lapsed on the fee record
Ended Mar 6, 2019 · From the USPTO record
Lapsed on the fee recordEnded Mar 6, 2019From the USPTO record
US 6,075,031Use of creatine analogues and creatine kinase modulators for the prevention and treatment of glucose metabolic disorders
Formerly held
Term ended
Term ended Aug 19, 2017 · From the USPTO record
Term endedTerm ended Aug 19, 2017From the USPTO record
US 7,285,573Use of Creatine or Creatine Analogs for the Treatment of Diseases of the Nervous System
Formerly held
Term ended
Term ended Mar 11, 2015 · Medium confidence
Term endedTerm ended Mar 11, 2015Medium confidence
US 6,706,764Use of creatine or creatine analogs for the treatment of diseases of the nervous system
Formerly held
Term ended
Term ended Nov 8, 2014 · From the USPTO record
Term endedTerm ended Nov 8, 2014From the USPTO record
US 5,998,457Creatine analogues for treatment of obesity
Term ended
Term ended no later than Dec 7, 2019 · Low confidence
Term endedTerm ended no later than Dec 7, 2019Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited